Corrigendum to “No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia” [J Infect 88 (2024) 106161]
Wei J. et al, (2024), Journal of Infection, 89, 106361 - 106361
Predicting individual patient and hospital-level discharge using machine learning
Wei J. et al, (2024), Communications Medicine, 4
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels KB. et al, (2024), Nature Communications, 15
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms
Citarella BW. et al, (2024), Heliyon, e29591 - e29591
Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection
Gu Q. et al, (2024), Journal of Infection, 88, 106156 - 106156
Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes.
Xie J. et al, (2024), Nature communications, 15
Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection.
Gu Q. et al, (2024), The Journal of infection
Therapeutic application of circular RNA aptamers in a mouse model of psoriasis
Guo SK. et al, (2024), Nature Biotechnology
Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs
Han W. et al, (2023), Cell Stem Cell, 30, 1624 - 1639.e8
Prime editor-mediated functional reshaping of ACE2 prevents the entry of multiple human coronaviruses, including SARS-CoV-2 variants
Zhao W. et al, (2023), MedComm, 4
Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study
Eyre DW. et al, (2023), The Lancet Infectious Diseases, 23, 922 - 932
HLA Alleles, COVID-19 Vaccine Antibody Response and Real-World Breakthrough Outcomes
Prieto-Alhambra D. et al, (2023)
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Wei J. et al, (2023), Nature Communications, 14
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
Highly efficient prime editing by introducing same-sense mutations in pegRNA or stabilizing its structure
Li X. et al, (2022), Nature Communications, 13
Knockout of circRNAs by base editing back-splice sites of circularized exons
Gao X. et al, (2022), Genome Biology, 23
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
Vihta1 KD. et al, (2022), Clinical Infectious Diseases
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Abbas A. et al, (2022), Scientific Data, 9
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
Wei J. et al, (2022), Nature Communications, 13